
Intuitive Surgical (ISRG) Stock Forecast & Price Target
Intuitive Surgical (ISRG) Analyst Ratings
Bulls say
Intuitive Surgical is well positioned for durable growth because its da Vinci ecosystem combines high-margin systems, instruments, disposables, and services with a large and expanding installed base of more than 11,000 systems worldwide and over 6,600 in the US. The company’s 3Q results showed resilient fundamentals, including revenue of $3.049 billion, adjusted EPS of $3.00, 546 da Vinci placements, and procedure growth of about 15%, with especially strong DV5 and SP adoption supporting future utilization and replacement demand. Although near-term US procedure growth and extended-use pricing actions may create some revenue-per-procedure pressure, its leadership in robotic surgery, low market penetration, and ongoing expansion in ASCs, Europe, Japan, and emerging markets support a positive long-term outlook.
Bears say
Intuitive Surgical is facing a weaker fundamental setup as U.S. da Vinci procedure growth decelerated to 10% in Q3 from 12% in Q2 and 14% in Q1, while management’s procedure guidance only narrowed to 14%-15% instead of being raised outright, leaving investors without clear evidence that U.S. volume trends have bottomed. China adds another layer of pressure because it is only 5%-6% of global procedures yet remains challenging, with policy-driven charge code changes set to weigh on I&A per-procedure revenue beginning in November 2026 and pricing actions implying a 3%-5% headwind to revenue per procedure. Although gross margin guidance was lifted to 68.7%-69.3% and dV5 momentum is encouraging, extended-use pricing and tougher competition threaten 2027 revenue per procedure and could offset operating leverage if adoption and procedure growth fail to reaccelerate.
This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.
Intuitive Surgical (ISRG) Analyst Forecast & Price Prediction
Start investing in Intuitive Surgical (ISRG)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Intuitive Surgical (ISRG) Forecast
Intuitive Surgical (ISRG) Analyst Forecast & Price Prediction
Start investing in Intuitive Surgical (ISRG)
Order type
Buy in
Order amount
Est. shares
0 shares